Related Experiment Videos
Diagnostic difficulties associated with phaeochromocytoma--4 case illustrations
Singapore Medical Journal
|April 29, 1998
Summary
Diagnosing phaeochromocytoma is challenging. A new test measuring urinary total metanephrine is highly sensitive and specific, improving detection rates for this rare tumor.
Area of Science:
- Biochemistry
- Endocrinology
- Oncology
Background:
- Phaeochromocytoma diagnosis is often delayed due to non-specific symptoms and limitations of existing tests.
- The 24-hour urinary vanillyl mandelic acid (VMA) test, historically used in Singapore, exhibits variable sensitivity for phaeochromocytoma detection.
- High performance liquid chromatography (HPLC) assays for urinary catecholamines and metanephrines were introduced in 1993.
Observation:
- This study reports on 4 phaeochromocytoma cases diagnosed since 1993 at Singapore General Hospital.
- Clinical presentations of these patients were diverse, highlighting diagnostic challenges.
- Urinary catecholamine and metabolite levels were compared between phaeochromocytoma patients and controls.
Findings:
- The traditional urinary VMA test showed 100% sensitivity but only 31% specificity for phaeochromocytoma.
- A urinary total metanephrine level of ≥9,000 nmol/day demonstrated both 100% sensitivity and 100% specificity.
- HPLC measurement of urinary total metanephrines offers superior diagnostic accuracy compared to urinary VMA.
Implications:
- The adoption of HPLC for urinary metanephrine measurement significantly enhances phaeochromocytoma diagnosis in Singapore.
- Improved diagnostic accuracy can lead to earlier treatment and better patient outcomes.
- This biochemical marker provides a reliable tool for identifying phaeochromocytoma, reducing diagnostic delays.